Analysis of the progostic value of the quantification of plasmatic epidermal growth factor receptor (EGFR) in advanced non-small cell lung cancer (NSCLC) patients

被引：0
|
作者：
Sirera, R. [1 ]
Camps, C. [1 ]
Lopez-Vivanco, G. [2 ]
Garcia-Campelo, R. [3 ]
Provencio, M. [4 ]
Gonzalez-Larriba, J. [5 ]
de las Penas, R. [6 ]
Iranzo, V. [1 ]
Taron, M. [7 ]
Rosell, R. [7 ]
机构：
[1] Hosp Gen Univ, Valencia, Spain
[2] Hosp Cruces, Bilbao, Spain
[3] Hosp Juan Canalejo, La Coruna, Spain
[4] Hosp Puerta Hierro, Madrid, Spain
[5] Hosp Clin San Carlos, Madrid, Spain
[6] Hosp Prov, Castellon de La Plana, Spain
[7] Hosp Badalona Germans Trias & Pujol, Badalona, Spain
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71419-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6591
引用
收藏
页码：385 / 386
页数：2
相关论文
共 50 条
  • [1] The quantification of epidermal growth factor receptor (EGFR) in plasma is a prognostic factor in advanced non-small cell lung cancer (NSCLC) patients
    Camps, C.
    Sirera, R.
    Munoz-Navarro, M.
    Lopez-Vivanco, G.
    Alonso, G.
    Provencio, M.
    Gonzalez-Larriba, J.
    de las Penas, R.
    Taron, M.
    Rosell, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Epidermal Growth Factor Receptor (EGFR) Mutation Testing in non-small cell lung cancer (NSCLC) patients
    Wallace, Andrew
    Howard, E.
    Dutton, L.
    Elles, R. G.
    Newman, W.
    [J]. JOURNAL OF MEDICAL GENETICS, 2010, 47 : S66 - S66
  • [3] Epidermal Growth Factor Receptor (EGFR) mutation testing in non-small cell lung cancer (NSCLC) patients
    Eaton, Helen
    Dutton, L.
    Wallace, A. J.
    Howard, E.
    Gaunt, L.
    Blackhall, F.
    Newman, W.
    [J]. JOURNAL OF MEDICAL GENETICS, 2011, 48 : S72 - S72
  • [4] THE EFFECTS OF EPIDERMAL GROWTH FACTOR (EGFR) RECEPTOR INHIBITORS ON THE IMMUNE SYSTEM IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Meniawy, Tarek
    Lake, Richard
    Nowak, Anna K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S374 - S374
  • [5] Mutations of the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer (NSCLC).
    Sonobe, M
    Katakura, H
    Adachi, T
    Wada, H
    Tanaka, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 637S - 637S
  • [6] The quantification of plasmatic free DNA is a prognostic factor in advanced non-small cell lung cancer (NSCLC) patients
    Camps, C.
    Sinera, R.
    Bremnes, R. M.
    Blasco, A.
    Safont, M. J.
    Caballero, C.
    Cabrera-Pastor, A.
    Gavila, J.
    Taron, M.
    Rosell, R.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 379 - 379
  • [7] Epidermal growth factor receptor (EGFR) mutation testingin non-small cell lung cancer (NSCLC) patients (pts).
    Sequist, L. V.
    Joshi, V. A.
    Jänne, P. A.
    Fidias, P.
    Muzikansky, A.
    Meyerson, M.
    Haber, D. A.
    Kucherlapati, R.
    Johnson, B. E.
    Lynch, T. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 408S - 408S
  • [8] EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION ANALYSIS IN NON-SMALL CELL LUNG CANCER (NSCLC) IN AN IRISH POPULATION
    Graham, Donna M.
    O'Connor, Kate
    Teo, Min Y.
    Burke, Louise
    Mccarthy, Julie
    O'Dea, Pauline
    O'Keefe, Margaret
    Moylan, Eugene J.
    Power, Derek G.
    O'Reilly, Seamus
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1527 - S1528
  • [9] MOLECULAR PROFILING OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) PATHWAY IN THE MANAGEMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS)
    Nuzzo, C.
    Sperduti, I.
    Marchetti, A.
    Cianciulli, A. M.
    Mottolese, M.
    Buttitta, F.
    Visca, P.
    Cecere, F. L.
    Cognetti, F.
    Milella, M.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 105 - 105
  • [10] Changes in Circulating Epidermal Growth Factor Receptor (EGFR) during Radiotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients
    Ye, Ping
    Zhao, Jing
    Maihle, Nita
    Wang, Shulian
    Jin, Jianyue
    Kong, Feng-Ming
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S605 - S605
12345